Join AlphaMaven

The Home Of Private Equity

Register For Free Learn More Contact Us

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Private Equity Dashboard:

Click to subscribe to our Free Daily Newsletter

Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

Healthcare & Life Sciences Private Equity Deal Tracker: Viewside Capital and Morningside Invest in Resilience Lab
1yr ago Venture Capital Private Equity thehealthcareinvestor Views: 290

Viewside Capital Partners and Morningside Group have co-led a $15 million series A funding round in Resilience Lab, according to a news release.

Resilience Lab, based in New York, is a mental health technology company. Founded in 2019, the company’s platform is designed to help clients connect to therapists and participate in in-person, telehealth or hybrid sessions. 

Viewside, based in Dallas, is a healthcare private equity firm. The firm is focused on making $3 million to $15 million growth equity investments in small and middle market companies within the healthcare technology and service sectors.

Morningside, based in Boston and founded in 1986, makes private equity and venture capital investments in the science and technology sectors. 


Today's Private Equity Headlines:

Most popular| Most recent
FEATURED MEMBER POST
Andrea Alms Video:  Money In Motion 101 - Deep Dive - Immunotherapy Cancer Market
Private Equity BrookDell Partners #Video
The Merger Cases That Will Matter At ABA Antitrust Meeting
1w ago Private Equity law360
10 states facing the highest risks from private equity
1w ago Private Equity bing
6 Monks Becomes First Alternative Investment Fund in Luxembourg to Offer Web3, Crypto Services for Third Party Funds - CoinTrust
1w ago Private Equity cointrust
Archimed acquires skincare products maker Cellese
1w ago Private Equity pehub
Deal Roundup: Vista’s $1.25bn Model N play, Triton agrees V&N Group buyout
1w ago Private Equity altassets
How Justin Ishbia Built One Of America's Most Successful Private Equity Firms - Forbes
1w ago Private Equity forbes
Alternative assets give pension funds options to expand investment menu - Business Daily
1w ago Private Equity businessdailyafrica
Physician Compensation in the PPM Context, With Justin Chamblee and Holly Buckley
1w ago Private Equity thehealthcareinvestor
Federal concerns mount over private equity hospital staffing, patient care in S. Colorado
1w ago Private Equity bing
Amy Kennedy Quoted by 9fin on Key ESG and LevFin Trends
1w ago Private Equity akingump
Fintech Investment Biz To Go Public Via $700M SPAC Merger
1w ago Private Equity law360
Esprit in Talks With Private Equity Firm for Potential Investments - The Wall Street Journal
1w ago Private Equity wsj
Federal concerns mount over private equity hospital staffing, patient care in S. Colorado - KRDO
1w ago Private Equity krdo
Hong Kong’s VMS loses CIO amid raft of senior departures
1w ago Private Equity privateequityinternational
Texas pension returns nearly 10% in HF program
1w ago Private Equity alternativeswatch
SMBC Aviation Capital promotes VP corporate finance
1w ago Private Equity airfinancejournal
Tech M&A Reigns Supreme In Q1 After Rare Hiccup In Q4
1w ago Private Equity law360
Sidley Crosses $3B in Revenue, With Growing 'Share' of Private Equity Market, Focus on Top Talent
1w ago Private Equity bing
Hotel chain Motel One valued at €4.1bn as hospitality dealmaking heats up
1w ago Private Equity ft
Regulatory Minutes: Part 3
1w ago Private Equity akingump
Macy's Sued In Del. To Block 'Dead Hand' Buyout Defense
1w ago Private Equity law360
Innovative Solutions For Your Trickiest People Problems
1w ago Private Equity rhythmsystems
Hedge fund launches stuck in neutral as performance picks up
1w ago Private Equity alternativeswatch
DFW’s North American Rail Solutions buys Condor Signals and Communications  
1w ago Private Equity pehub
Does private credit generate excess returns?
1w ago Private Equity ft
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
Join to Search Member Profiles
View Private Equity Listings
AlphaMaven Daily Indices
Apr MTD ROR
AlphaMaven Private Equity Index:
3.8%
- more -
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Andrea Alms Video:  Money In Motion 101 - Deep Dive - Immunotherapy Cancer Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 97 - The Chemotherapy Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 100 - Cancer Market Wrap-Up
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 99 - Immunology Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 102 - Deep Dive Immunotherapy Cancer Market Part 3
- posted by: BrookDell Partners
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.